|HYLD||Barclays U.S. High Yield Index|
|Yield to Maturity||10.58%||6.28%|
|Duration||2.56 years||4.04 years|
|Number of Holdings||72|
|30-Day SEC Unsubsidized Yield||9.49%|
|30-Day SEC Subsidized Yield||9.49%|
Past Performance is not indicative of future results. HYLD statistics and industry breakdowns are for the actual HYLD security holdings as of the listed date, excluding cash, and the coupon, maturity in years, modified duration, yield to maturity, and ratings breakdown additionally exclude non-fixed income holdings, such as equities. For the purposes of the duration calculation, equity holdings have been excluded and loans assigned a duration of 0.25. Yield to Maturity is the yield if the security is held until the maturity date. Duration is the change of a fixed income security that will result from a 1% change in interest rate. HYLD uses a modified duration calculation and the Barclays High Yield Index a Macaulay duration calculation, both based on the yield to worst date. Current Yield is the bond’s annual coupon income divided by the bond’s current price. 12-Month Yield is the sum of the company’s interest and dividend payments over the last twelve months divided by the fund NAV as of the listed date, expressed as a percentage. 30–Day SEC Yield (Standardized Yield) is an annualized yield furnished by the Fund's custodian that is calculated by dividing the investment income earned by the Fund less expenses over the most recent 30-day period by the current maximum offering price. The Subsidized Yield reflects fee waivers and/or expense reimbursements recorded by the Fund during the period. Without waivers and/or reimbursements, yields would be reduced. The Unsubsidized Yield does not adjust for any fee waivers and/ or expense reimbursements in effect. If the Fund does not incur any fee waivers and/or expense reimbursements during the period, the 30-Day Subsidized Yield and 30-Day Unsubsidized Yield will be identical.
|S&P Issuer Rating (ex-cash, equities)||Holdings|
The S&P Issuer Credit Ratings have been provided for the debt holdings in the HYLD ETF, excluding cash and equity investments. The Standard & Poor's Issuer Credit Rating is a forward-looking opinion about an obligor's overall financial capacity (its creditworthiness) to pay its financial obligations. In certain cases when an S&P Issuer Credit Rating was not provided, we utilized the S&P Bond, or issue specific, rating.
The credit ratings are published rankings based on detailed financial analyses by a credit bureau specifically as it relates the bond issue's ability to meet debt obligations. The highest rating is AAA, and the lowest is D. Securities with credit ratings of BBB and above are considered investment grade.
|NAV||Market Price Return||Barclays U.S. High Yield Index|
|NAV||Market Price Return||Barclays U.S. High Yield Index|
Performance data quoted represents past performance and is no guarantee of future results. Current performance may be lower or higher than the performance data quoted. Investment return and principal value will fluctuate so that an investor’s shares, when redeemed, may be worth more or less than original cost. Returns less than one year are not annualized.
The Barclays U.S. High Yield Index is an unmanaged index considered representative of the universe of U.S. fixed rate, non investment grade debt. One cannot invest directly in an index.
|Ex-Date||Record Date||Pay Date||Cash Div||ST Cap Gain||LT Cap Gain||Return of Capital||Total Distribution|
Timothy Gramatovich, Chief Investment Officer
Mr. Gramatovich, co-founder of Peritus, has nearly 30 years of experience directly involved in the high yield asset class. As the Chief Investment Officer, he leads the investment committee and is responsible for developing investment strategies, themes, and ideas. Prior to co-founding Peritus, Mr. Gramatovich was a Portfolio Manager with Smith Barney’s Asset Management Division in Los Angeles, where he managed high yield portfolios for high net worth individuals and institutions. He began his career with Drexel Burnham Lambert in 1984, assisting in the development and marketing of high yield corporate debt management products. Mr. Gramatovich is a Chartered Financial Analyst (“CFA”) charter holder and a member of the CFA Institute. He is a graduate of the New York Institute of Finance.
Ronald Heller, CEO & Senior Portfolio Manager
Mr. Heller, co-founder of Peritus, is the Senior Portfolio Manager, overseeing portfolio management and trading activities. Over the past 19 years, Mr. Heller has developed long standing relationships with dealers across Wall Street for new issue and secondary trading. He began his career in finance in 1993 with Smith Barney. Prior to Mr. Heller’s investment career, he had a seven year career in the National Football League with San Francisco, Atlanta and Seattle, retiring in 1993. Mr. Heller attended Oregon State University majoring in Kinesiology.
|4PM Bid/Offer Midpoint||$47.95||Premium/Discount||$-0.17|
|Assets Under Management||$668,859,335.04|
|Premium/Discount Historical Data|
|SEITEL INC 9.5 4/15/2019||99||2.01%|
|CREDITCORP 12 7/15/2018||102.5||1.97%|
|UCI INTERNATIONAL INC 8.625 2/15/2019||96.5||1.89%|
|TALOS PRODUCTION LLC/FIN 9.75 2/15/2018||101.25||1.85%|
|GLOBAL TEL LINK 5/13 2ND LIEN C 11/23/20 TERM LOAN||99.458||1.84%|
|AMERICAN PA 02/27/19 TERM LOAN||100.5||1.79%|
|SITEL LLC/SITEL FIN CORP 11.5 4/1/2018||89.375||1.79%|
|TRILOGY INTL PART LLC 10.25 8/15/2016||101.875||1.75%|
|EARTHLINK HOLDINGS CORP 8.875 5/15/2019||97.75||1.75%|
|SHEARER'S FOODS 6/14 COV-LITE 2 06/30/22 TERM LOAN||98.25||1.68%|
Shares are bought and sold at market price (closing price) not NAV and are not individually redeemed from the Fund. Market price returns are based on the midpoint of the bid/ask spread at 4:00 pm Eastern Time (when NAV is normally determined), and do not represent the return you would receive if you traded at other times. Holdings and allocations are subject to risks and to change. A holding identified with an "MM" at the end of its name indicates it is a Money Market fund.
Gross Expense Ratio
Fee Waiver and/or Expense Reimbursement
Net Expense Ratio